Epstein-Barr virus lymphoproliferation after bone marrow transplantation.
暂无分享,去创建一个
[1] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[2] Jiu-Yao Wang,et al. Graft Versus Host Disease in Allogeneic Bone Marrow Transplantation , 1987 .
[3] L. Lum. The kinetics of immune reconstitution after human marrow transplantation. , 1987, Blood.
[4] H. Deeg,et al. Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease. , 1986, Blood.
[5] R. Storb,et al. Marrow transplantation from related donors other than HLA-identical siblings. , 1985, The New England journal of medicine.
[6] J. Finlay,et al. Prophylactic acyclovir in patients receiving bone marrow transplants. , 1985, The New England journal of medicine.
[7] S. Orkin,et al. Phenotype of recovering lymphoid cell populations after marrow transplantation , 1985, The Journal of experimental medicine.
[8] R. Warnke,et al. Epstein-Barr virus-associated B-cell proliferations of diverse clonal origins after bone marrow transplantation in a 12-year-old patient with severe combined immunodeficiency. , 1985, The New England journal of medicine.
[9] R. Simmons,et al. Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation. , 1985, Transplantation.
[10] J. Kersey,et al. Graft-versus-host disease prophylaxis with anti-T-cell monoclonal antibody OKT3, prednisone and methotrexate in allogeneic bone-marrow transplantation. , 1985, British journal of haematology.
[11] Swee Lay Thein,et al. Hypervariable ‘minisatellite’ regions in human DNA , 1985, Nature.
[12] J. Wingard,et al. Detection of Epstein-Barr virus DNA in mouthwashes by hybridization , 1985, Journal of clinical microbiology.
[13] J. Sullivan,et al. Lymphoma of host origin in a marrow transplant recipient in remission of acute myeloid leukemia and receiving cyclosporin A , 1985, American journal of hematology.
[14] J. Pagano,et al. Epstein-Barr virus transformation of human B lymphocytes despite inhibition of viral polymerase , 1985, Journal of virology.
[15] J. Hansen,et al. Fatal Epstein-Barr-virus-associated proliferation of donor B cells after treatment of acute graft-versus-host disease with a murine anti-T-cell antibody. , 1984, Annals of internal medicine.
[16] J. Sklar,et al. LYMPHOPROLIFERATIVE DISORDERS IN CARDIAC TRANSPLANT RECIPIENTS ARE MULTICLONAL LYMPHOMAS , 1984, The Lancet.
[17] N. Raab-Traub,et al. Epstein-Barr virus replication in oropharyngeal epithelial cells. , 1984, The New England journal of medicine.
[18] T. Starzl,et al. REVERSIBILITY OF LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN-STEROID THERAPY , 1984, The Lancet.
[19] R. Warnke,et al. Monoclonality of lymphoproliferative lesions in cardiac-transplant recipients. Clonal analysis based on immunoglobulin-gene rearrangements. , 1984, The New England journal of medicine.
[20] T. Waldmann,et al. Immunoglobulin-gene rearrangements as unique clonal markers in human lymphoid neoplasms. , 1983, The New England journal of medicine.
[21] J. Parker,et al. Reactive lymphoid hyperplasia with single class (monoclonal) surface immunoglobulin. , 1983, American journal of clinical pathology.
[22] T. Waldmann,et al. Immunoglobulin gene rearrangement and cell surface antigen expression in acute lymphocytic leukemias of T cell and B cell precursor origins. , 1983, The Journal of clinical investigation.
[23] K. Sullivan,et al. Analysis of late infections after human bone marrow transplantation: role of genotypic nonidentity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graft-versus-host disease. , 1982, Blood.
[24] R. Hackman,et al. A monoclonal immunoblastic sarcoma in donor cells bearing Epstein-Barr virus genomes following allogeneic marrow grafting for acute lymphoblastic leukemia. , 1982, Blood.
[25] R. Palmiter,et al. Differential regulation of metallothionein-thymidine kinase fusion genes in transgenic mice and their offspring , 1982, Cell.
[26] M. Epstein,et al. EPSTEIN-BARR-VIRUS-SPECIFIC T-CELL MEMORY IN RENAL-ALLOGRAFT RECIPIENTS UNDER LONG-TERM IMMUNOSUPPRESSION , 1982, The Lancet.
[27] J. Najarian,et al. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. , 1981, Cancer research.
[28] J. Rosai,et al. Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients. , 1981, Cancer research.
[29] R. White,et al. A highly polymorphic locus in human DNA. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[30] J. Shaw,et al. Acyclovir inhibition of Epstein-Barr virus replication. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[31] J. Rosai,et al. Lymphoreticular disorders in primary immunodeficiencies: New findings based on an up‐to‐date histologic classification of 35 cases , 1980, Cancer.
[32] B. Lange,et al. Epstein‐Barr virus‐related serology in marrow transplant recipients , 1980, International journal of cancer.
[33] K. Cantell,et al. Epstein-Barr virus infection in renal transplant recipients. Effects of antithymocyte globulin and interferon. , 1980, Annals of internal medicine.
[34] J. Kalbfleisch,et al. The Statistical Analysis of Failure Time Data , 1980 .
[35] E. Kieff,et al. Epstein-Barr virus (B95-8) DNA VII: molecular cloning and detailed mapping. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[36] J. Shaw,et al. Effect of acyclovir [9-(2-hydroxyethoxymethyl)guanine] on Epstein-Barr virus DNA replication , 1980, Journal of virology.
[37] C. Taylor,et al. Immunoblastic sarcoma in donor cells after bone-marrow transplantation. , 1979, The New England journal of medicine.
[38] W. Henle,et al. Antibodies to Epstein-Barr virus-associated nuclear antigen in infectious mononucleosis. , 1974, The Journal of infectious diseases.
[39] G. Miller,et al. Oropharyngeal excretion of Epstein-Barr virus by renal transplant recipients and other patients treated with immunosuppressive drugs. , 1974, Lancet.
[40] C. Abildgaard,et al. Prevalence of oropharyngeal excreters of leukocyte-transforming agents among a human population. , 1973, The New England journal of medicine.
[41] G. Klein,et al. Cellular localization of an Epstein‐Barr virus (EBV)‐associated complement‐fixing antigen in producer and non‐producer lymphoblastoid cell lines , 1973, International journal of cancer.
[42] B. Leventhal,et al. IMMUNOCOMPETENCE FOLLOWING ALLOGENEIC BONE MARROW TRANSPLANTATION IN MAN , 1972, Transplantation.
[43] E. Perlin,et al. Oral excretion of Epstein-Barr virus by healthy subjects and patients with infectious mononucleosis. , 1972, Lancet.
[44] D. Purtilo. Immune deficiency and cancer : Epstein-Barr virus and lymphoproliferative malignancies , 1984 .